8-K

$BSX · Boston Scientific Corporation

November 17, 2026 · AI-analyzed SEC filing · Verify material figures against the official SEC.gov filing

On November 17, 2026, Boston Scientific Corporation filed a Form 8-K reporting that its Board of Directors, upon the recommendation of the Executive Compensation and Human Resources Committee, approved the company’s 2027 Annual Bonus Plan. The plan covers the performance year from January 1, 2027 through December 31, 2027, and provides annual cash incentive opportunities for eligible exempt and nonexempt indirect labor or equivalent personnel, including named executive officers.

The plan is substantially similar to the 2026 annual bonus plan. It creates an aggregate bonus pool equal to total target annual bonuses multiplied by a distribution percentage, plus a dynamic bonus pool of up to 10% of total target bonuses. After the performance year, the Compensation Committee will determine the distribution percentage between 0% and 150% based on company-wide goals for global sales and adjusted earnings per share, with Board discretion to reduce it based on quality objectives and quality systems performance. Managers then assign individual performance modifiers between 0% and 150%, resulting in a maximum individual payout potential of 0% to 225% of target bonus.

Awards to certain executive officers are subject to the company’s discretionary recoupment policy and its Dodd-Frank Clawback Policy. The filing also includes the full text of the 2027 Annual Bonus Plan as Exhibit 10.1 and references the 2027 Performance Share Programs.

Get filings like this before the market reacts.

Real-time SEC filing alerts, AI summaries, and a free daily digest — plus portfolio tracking that ties filings to your positions.

Start your free trial →